Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

CureVac N.V (CVAC) Equity Ratio: 2019-2024

  • CureVac N.V's Equity Ratio rose 32.31% to 0.87 in Q4 2024 from the same period last year, while for Dec 2024 it was 0.87, marking a year-over-year increase of 32.31%. This contributed to the annual value of 0.87 for FY2024, which is 32.31% up from last year.
  • Per CureVac N.V's latest filing, its Equity Ratio stood at 0.87 for Q4 2024, which was up 32.31% from 0.66 recorded in Q4 2023.
  • In the past 5 years, CureVac N.V's Equity Ratio registered a high of 0.87 during Q4 2024, and its lowest value of 0.47 during Q4 2020.
  • Moreover, its 3-year median value for Equity Ratio was 0.66 (2023), whereas its average is 0.71.
  • Data for CureVac N.V's Equity Ratio shows a peak YoY soared of 243.64% (in 2020) over the last 5 years.
  • Quarterly analysis of 5 years shows CureVac N.V's Equity Ratio stood at 0.47 in 2020, then climbed by 26.29% to 0.59 in 2021, then increased by 4.26% to 0.62 in 2022, then increased by 5.82% to 0.66 in 2023, then skyrocketed by 32.31% to 0.87 in 2024.
  • Its Equity Ratio stands at 0.87 for Q4 2024, versus 0.66 for Q4 2023 and 0.62 for Q4 2022.